Basic Information
ONGLYZA
0310-6100
Regulatory Information
0310-6100
NDA022350
C73594
October 24, 2019
USA
These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets, for oral useInitial U.S. Approval: 2009
HUMAN PRESCRIPTION DRUG LABEL
23
Company Information
054743190
Active Ingredients
magnesium stearate
Code: 70097M6I30
Class Code: IACT
lactose monohydrate
Code: EWQ57Q8I5X
Class Code: IACT
MICROCRYSTALLINE CELLULOSE
Code: OP1R32D61U
Class Code: IACT
croscarmellose sodium
Code: M28OL1HH48
Class Code: IACT
Active Moieties
saxagliptin anhydrous
Code: 8I7IO46IVQ